Test 5 Review Flashcards

0
Q

Intrapatient therapeutic variability

A

Different response in the same patient at different times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Interpatient therapeutic variability

A

Different response between different people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacokinetic variability

A

Varying of delivery, removal, efficacy, and toxicity of drug (body does to drug)
-dangerous to drugs with a narrow therapeutic index (more likely to be fatal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What plays a vital role in pharmacokinetic variability?

A

Genetic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is body weight and composition a source of pharmacokinetic variability?

A

Obese person has a higher volume of distribution for lipophilic drugs (dissolve in fat and spread farther) so they need a smaller dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How to find dose required?

A

(Avg dose/70kg) x weight in kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is age a source of pharmacokinetic variability?

A

Very young or old people have a worse immune system and enzymes are too weak to absorb the medication correctly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are infants and children at higher risk of greater bioavailability?

A

They have increased permeability of membranes such as the BBB, they have increased water content, decreased blood flow, metabolism, and renal clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why do the elderly have risk of greater bioavailability?

A

Decreased liver and kidney function and a higher plasma concentration (liver can’t metabolize well and kidney can’t eliminate well)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is sex a source of pharmacokinetic variability?

A

Women have higher fat content, therefore more volume of distribution for lipophilic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why does pregnancy and lactation affect pharmacokinetic variability?

A

Teratogenicity (drugs crossing placenta and affecting fetus) and it is unknown how some drugs will affect a pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fetal Alcohol Syndrome-FAS

A

Woman either drinks during pregnancy or takes a drug that affects the child, resulting in a malformed face “teratogenic effect”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does health and disease affect pharmacokinetic variability?

A

Kidney and liver disease will affect variability, dehydration, malnutrition, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacodynamic variability

A

What the drug does to the body

-variable drug effects due to difference in structure and function of target organs or patient disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is sex a source of pharmacodynamic variability?

A

Females are more responsive to pain medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is idiosyncrasy a source of pharmacodynamic variability?

A

Idiosyncrasy is an unpredictable and unusual response that is undocumented, usually a genetic predisposition, so it can affect what the drug does to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why are circadian rhythms a source of pharmacodynamic variability?

A

Because chemicals like histamine and sex hormones are highest at night, and cortisol is highest in the morning so they can affect what the drug does to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why does drug tolerance a source of pharmacodynamic variability?

A

If someone is tolerant to a drug they need more and more, so an increased dose can affect what the drug does to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tachyphylaxis

A

Rapidly increasing response to a drug after administering a few doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why is receptor regulation by drugs a source of pharmacodynamic variability?

A

It can result in either tolerance or a more pronounced effect, so it can influence what the drug does to the body
-receptor up and receptor down regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Receptor up regulation

A

Number of receptors increase with continuous administration of drug, resulting in too many places for the drug to attach, causing a rebound (more pronounced) drug effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Receptor down regulation

A

Number of receptors decrease with continuous administration, results in not enough places for the drug to attach leading to tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why is drug resistance a source of pharmacodynamic variability?

A

Because 3 types of resistance lead to absorption and elimination problems, affecting what the drug does to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Intrinsic resistance

A

Resistance to causing activity when attached to a receptor, leads to decreased absorption or increased elimination, and decreased response to the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Acquired genetic resistance

A

Resistance that is acquired through a person’s genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Cross resistance

A

Resistance to one drug causes resistance to similar drugs that use the same enzyme system (multiple drug resistance)
-must change the resistant drug to find another drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Drug allergy

A

Adverse side effect that can cause rashes, itchy eyes, swollen face, or anaphylactic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Mechanism of drug allergy

A

B lymphocytes activate antibodies that attach to the mast cell, and upon second exposure the mast cell releases histamine that causes the allergic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Drug compliance

A

Willingness and ability to stick to correct doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Causes of non-compliance

A

Too many medications, cost, side effects, lack of understanding
MOST COMMON CAUSE IS SIDE EFFECTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

FDA

A

Food and drug administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What does the FDA do?

A

Regulates development of new drug products and marketing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the FDA’s functions?

A
  1. Promote and protect public health
  2. Monitor product after it is in use
  3. Regulates products (food products, tissues of transplantation, cosmetics, electronic devices that emit radiation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Federal Food, Drug, and Cosmetic Act of 1938

A

Single most important act related to the FDA, gave authority to the FDA for them to regulate food, drugs, and cosmetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Steps of new drug development

A
  • Select the lead compound and check for affinity, efficacy, early ADME, toxicity
  • preclinical testing (on animals, checks for efficacy, toxicology, ADME processes then move to humans)
  • investigational new drug (IND, must be approved by the IRB)
  • clinical trials on humans with the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Institutional review board

A

IRB
Reviews and approves research on a drug before it is classified as an investigational new drug and proceeds to clinical trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

4 Phases of Drug Trials

A
  1. Small number of healthy volunteers-safety, toxicology, and pharmacokinetics (is it safe?)
  2. Small number of people with disease-efficacy, dosing, and adverse effects (does it work?)
  3. Larger number of sick patients-compare to current treatment (is it better?)
  4. Post marker surveillance of drug’s effects-detects adverse effects (can it stay?)—can result in removal of a drug from the market and is completely voluntary, people must report side effects to the FDA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How long does the process take for drug research and approval?

A

It can take 10+ years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What happens between phases 3 and 4 of drug trials?

A

A 1-4 year period elapses between those stages where the drug is approved for sale on the market

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

polypharmacy

A

giving multiple drugs for multiple conditions, or multiple drugs to manage one condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

3 types of reactions

A

pharmaceutical, pharmacokinetic, and pharmacodynamic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

pharmaceutical reactions

A

drugs reacting chemically or physically during administration or absorption, altering the variability of one or both drugs–chelation, adsorption, altering gastric pH, and incompatibilities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

chelation

A

agents (chelating agents) bind to a drug forming an insoluble complex that is poorly absorbed
ex) tetracycline and ciprofloxacin (antibiotics)=insoluble complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

adsorption

A

physical binding of a drug with other solids, leading to increased absorption
ex) antacids adsorb and decrease absorption of iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

alteration of gastric pH

A

some drugs are used to increase pH, and may affect drugs that absorb better at a low pH
ex) omeprazole increases gastric pH, and decreases absorption of ampicilin

45
Q

incompatibilities

A

some drugs can decrease the effects of other drugs

ex) when IV fluids are mixed together they may be incompatible and decrease their effects

46
Q

what happens when meds are taken on an empty stomach?

A

the plasma concentration is very high since there is nothing else to absorb

47
Q

why should you not take meds with milk?

A

the medicine binds to the milk and forms an insoluble complex–this delays absorption and reduces effect

48
Q

what should you take medications with?

A

water

49
Q

pharmacokinetic interactions

A

changes to the ADME processes of another drug (what the body does to the drug

  • account for the most drug interactions
  • ADME processes, distribution interactions, excretion interactions, biotransformation interactions, enzyme induction and inhibition
50
Q

gastric motility and emptying time

A

low gastric emptying time-higher bioavailability, increased absorption from small intestine
high gastric emptying time-low bioavailability, decreased absorption and stays in stomach longer

51
Q

what is the normal gastric emptying time?

A

90 minutes

52
Q

intestinal flora

A

bacteria in the large intestine that help absorb drugs-if there are less bacteria, it leads to less metabolism and a high concentration b/c the medicine isn’t absorbed fast enough

53
Q

saturation of carrier mediated absorption

A

all receptor are occupied and the drugs can’t reach the target–low bioavailability and absorption

54
Q

distribution interactions

A

displaces the drug from the transporter, resulting in an increased plasma concentration and increased metabolism and excretion

55
Q

excretion interactions

A

changes urinary pH-increased urinary pH leads to decreased excretion of bases, increased excretion of acids (acids are 0-6 on scale, bases are 8-14)

56
Q

alteration of tubular secretion

A

tubular secretion is active transport with a specific transporter for acids and bases, and competition b/w these results in decreased secretion and clearance

57
Q

biotransformation interactions

A

affects metabolism of other drugs, and if a drug stays in the stomach too long it is less available for absorption

58
Q

enzyme induction

A

potentiated effect

ex) St. John’s wort induces CYP3A, and when given with other drugs it causes faster elimination

59
Q

enzyme inhibition

A

another drug is inhibited
ex) CYP3A is inhibited by grapefruit juice, increasing the bioavailability of the drug it is given with, leading to toxicity

60
Q

most important enzyme in the liver?

A

CYP3A, most often responsible for life threatening drug reactions and metabolized 55% of all drugs

61
Q

pharmacodynamic drug interactions

A

one drug changes the pharmacological effect of another (drug does to body, molecular and chem. interactions)
-additive, synergistic, and antagonistic reactions

62
Q

additive reaction

A

something is added

  • most common type of pharmacodynamic reaction
  • 1+1=2
63
Q

synergistic reaction

A

combined effect of the medications is greater than either of their individual effects
-1+1=3

64
Q

antagonistic reaction

A

results in inhibition

-classified as competitive, noncompetitive, etc

65
Q

tyramine

A

compound in cheese that causes hypertensive crisis if given with antidepressants, because it increases availability (toxicity) of the compound

66
Q

why can warfarin not be taken with greens?

A

greens have vitamin K, warfarin is an anti-vitamin K drug and an anticoagulant, so it renders warfarin ineffective

67
Q

what can replace the friendly bacteria killed by antibiotics?

A

compounds in yogurt

68
Q

why can drugs not be taken with alcohol?

A

alcohol has depressive properties and either an additive or synergistic reaction, so it leads to high blood pressure

69
Q

what happens when alcohol is taken with tylenol?

A

it produces a higher level of toxic metabolites, affecting the liver

70
Q

why is grapefruit juice bad for medications?

A

it binds to CYP3A, inhibiting it, increasing the toxicity and effect of the drug. also causes decreased metabolism

71
Q

what happens if herbal tea is taken with estrogen?

A

it leads to increased estrogen amounts

72
Q

what happens when St. John’s wort is given with the majority of medications?

A

it causes nausea, weakness, and fatigue

73
Q

what does warfarin do with some medications?

A

its effect as an anticoagulant is decreased causing increased bleeding and bruising

74
Q

pharmacogenetics

A

study of genetically determined variability in response of people to drugs
-studies specific differences

75
Q

pharmacogenomics

A

study of effect of person’s genetic inheritance on body’s response to drugs by studying multiple genes and alleles
-uses a genome wide approach, more broad than pharmacogenetics

76
Q

DNA

A

codes for producing genetic chemicals

77
Q

RNA

A

messenger, carries info through cytoplasm

78
Q

transcription

A

DNA->mRNA

takes place in the nucleus, a DNA strand untwists to form two single-strand mRNA molecules

79
Q

translation

A

mRNA->proteins
takes place in the ribosomes, the mRNA formed from transcription carries the message through the cytoplasm to the ribosomes to carry out translation

80
Q

how many chromosomes do humans have, and what are they called?

A
46 total (23 from sperm, 23 from egg)
22 pairs are called autosomes, and 23rd pair are the sex chromosomes (XX or XY)
81
Q

gene

A

sequence of DNA that encodes a particular trait

82
Q

complementary base pairs of DNA

A

adenine-thymine

guanine-cytosine

83
Q

2 alternative forms (alleles) of genes

A

homozygous-two same alleles (SS)

heterozygous-two different alleles (Sc)

84
Q

how many known genes are in the human genome?

A

30,000

85
Q

genotype

A

how genes are arranged–genetic makeup

86
Q

phenotype

A

physical expression of the genotype

87
Q

gene expression

A

manifestation of genotype into the phenotype

88
Q

mutation

A

occurs in less than 1% of population

permanent change or structural alteration of DNA

89
Q

germline mutation or hereditary mutation

A

mutation transmitted through germ cells (sex cells) through the generations

90
Q

acquired mutation

A

acquired through exposure to toxins (radiation, smoke, etc) that occurs in a single cell after conception and it spreads to all cells that multiply from it

91
Q

polymorphism

A

mutation that occurs in over 1% of population

92
Q

most common type of polymorphism

A

single nucleotide polymorphism–one of the nucleotides in the A-T G-C base pairs is replaced

93
Q

sickle cell anemia

A

a single amino acid changes in the hemoglobin, causing a RBC to form into a sickle shape and can’t function correctly

94
Q

glucose 6 phosphate dehydrogenase deficiency (G6PD)

A

most common enzyme deficiency, certain medications cause hemolysis (rupture of RBC)
-there are no obvious signs, and it is more common in males and african americans

95
Q

monogenic disease

A

1 gene is involved

-cystic fibrosis, huntington’s, sickle cell anemia

96
Q

polygenic disease

A

more than 1 gene is involved

-asthma, heart disease, Alzheimers

97
Q

gene deletion

A

leads to enzyme deficiency, leads to slow metabolizers–toxicity

98
Q

gene amplification

A

increased gene expression, leads to more enzyme and fast metabolizers (if the drug is eliminated too fast it can cause resistance)

99
Q

hyporesponsers

A

receptors are under-responding, some may be inactive and this leads to a low availability of the drug

100
Q

hyper-responders

A

receptors are over-responding, so a small dose could cause a large response

101
Q

variation can change the availability of drug transporters

A

decreased transporters=low availability, drug doesn’t reach target so no response
increased transporters=too much drug reached the target and causes too much of a response

102
Q

those that are slow metabolizers probably have a what?

A

genetic problem

103
Q

clinical applications of pharmacogenomics

A

help identify a group that will benefit from a drug and the group that will experience toxicity, so a drug can still be marketed

104
Q

benefits of pharmacogenomics on drug therapy

A

advanced disease screenings (people know their risks so make better lifestyle choices), drugs with more specific targets, choice of drugs and dose, and more universal drugs

105
Q

genetics

A

identification of disease susceptibility in genes and gene variants by studying patients

106
Q

genomics

A

identification of genes and gene families as drug targets based on sequence similarities

107
Q

functional genomics

A

understanding function of gene and variants

108
Q

identifying drug compound

A

finding compound that interacts appropriately with the target

109
Q

compound optimization

A

alteration of compound structure to optimize pharmacokinetic(ADME) and pharmacodynamic (drug to body, chemical reactions) properties